Final Medicare Regulations for 2027: Key Changes and Implications
The Centers for Medicare & Medicaid Services (CMS) recently announced final regulations for the 2027 Medicare Physician Fee Schedule and Quality Payment Program, deciding against proposed payment cuts for surgical pathology codes following advocacy from the College of American Pathologists (CAP).
This CMS decision arrived after public comments highlighted the potential negative impact of significant payment reductions on access to care. Previously, the Maryland Health Care Commission suggested the possibility of a review, with cuts up to 90% on surgical pathology codes. However, CMS has opted not to pursue this reevaluation for now, though future considerations are possible.
Potential Impacts and Future Outlook
Despite maintaining current payment levels, the field of pathology will see a 2.3% reduction in overall Medicare payments due to the expiration of previous relief measures. This poses a financial challenge for pathologists already grappling with increasing operational costs. As Medicare reforms are discussed in Congress, CAP is advocating for changes to account for inflation, urging its members to actively participate in these efforts through resources like the CAP Action Alert Center.
Quality Payment Program Shifts
In a significant shift for performance year 2027, CMS will phase out the traditional Merit-based Incentive Payment System (MIPS) by 2031, transitioning to mandatory MIPS Value Pathways (MVPs) beginning in 2029. Specifically, the Pathology MVP, introduced in 2026, targets pathologists with tailored quality measures and Improvement Activities, although not all standard MIPS criteria apply to them. This shift aims to streamline reporting and focus on core measures rather than previous "high-priority" quality measures.
Exemptions and Incentives
CMS plans to automate exemptions from MIPS for practices affected by extreme circumstances, simplifying compliance for eligible professionals. Furthermore, the Advanced Alternative Payment Model (APM) track participants will find MIPS requirements waived if they meet the criteria, and CMS has announced modifications to incentive payments for future years. These changes are designed to alleviate administrative burdens and ensure practices remain efficient in challenging circumstances.
| Year | Key Change | Implication |
|---|---|---|
| 2027 | CMS maintains current payment levels | Prevents drastic reductions in pathology reimbursements |
| 2029 | Transition to mandatory MVPs | Refines focus on core measures for pathologists |
| 2031 | Phase out of traditional MIPS | Simplified reporting structures |
Strategies for Pathology Practices
CAP continues to support its members by providing updates and guidance on navigating these complex changes in Medicare policy. Pathology practices should prioritize staying informed, engaging with advocacy efforts, and adapting to new reporting requirements to maintain efficiency and diagnostic quality. As these regulatory shifts unfold, pathologists will need to align their practices with the evolving landscape to sustain both clinical excellence and financial stability.